Prognostic value of primary tumour maximum standardized uptake value (SUV max) in non small cell lung cancer (NSCLC) with F18-fluorodeoxyglucose positron emission tomography (FDG-PET): a systematic review and meta-analysis (MA) by the European Lung Cancer

M. Dusart, T. Berghmans, M. Paesmans, C. Hossein-Foucher, C. Castaigne, A. Scherpereel, C. Mascaux, M. Moreau, M. Roelandts, S. Alard, A. P. Meert, J. J. Lafitte, N. Patz, J. P. Sculier (Brussels, Belgium; Lille, France; Durham, NC, United States Of Ameri

Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology

Session: Diagnosis and prognosis in thoracic oncology
Session type: Oral Presentation
Number: 1277

Disease area: Thoracic oncology

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Dusart, T. Berghmans, M. Paesmans, C. Hossein-Foucher, C. Castaigne, A. Scherpereel, C. Mascaux, M. Moreau, M. Roelandts, S. Alard, A. P. Meert, J. J. Lafitte, N. Patz, J. P. Sculier (Brussels, Belgium; Lille, France; Durham, NC, United States Of Ameri. Prognostic value of primary tumour maximum standardized uptake value (SUV max) in non small cell lung cancer (NSCLC) with F18-fluorodeoxyglucose positron emission tomography (FDG-PET): a systematic review and meta-analysis (MA) by the European Lung Cancer. Eur Respir J 2007; 30: Suppl. 51, 1277

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

The importance of positron emission tomography/computed tomography (PET-CT) to identify distant metastasis in non-small cell lung cancer (NSCLC) Source: Annual Congress 2010 - Staging of lung cancer Year: 2010
The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology Source: Eur Respir J 2001; 17: 802-820 Year: 2001
The effect of positron emission tomography (PET-CT) on the management of patients with non-small cell lung cancer (NSCLC) prior to oncological treatment Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014
Preoperative evaluation of locally advanced non-small cell lung cancer after induction therapy by positron emission tomography with F-18-fluorodeoxyglucose (FDG-PET) Source: Eur Respir J 2004; 24: Suppl. 48, 457s Year: 2004
Prognostic impact of FDG-PET in recurrence of surgically treated non-small cell lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005
Prognostic value of fluorine-18 fluorodeoxyglucose (18-FDG) positron emission tomography imaging in patients with non-small cell lung carcinoma Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012
The place of non-invasive techniques (CT - PET - CT) Source: Annual Congress 2007 - Mediastinal staging for NSCLC Year: 2007
The role of positron emission tomography scan in the preoperative staging of nonsmall cell lung cancer Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery Year: 2008
Integrated ¹⁸F – FDG PET dynamic contrast enhanced CT to phenotype non-small cell lung cancer Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011
Imaging in lung cancer: positron emission tomography scan Source: Eur Respir J 2002; 19: 49S-60S Year: 2002
False- positive and false-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in non-small-cell lung cancer Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014
Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration Source: Eur Respir J 2009; 33: 201-212 Year: 2009
The role of positron emission tomography with 18F-2-fluoro-2-deoxy-D-glucose in respiratory oncology Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-34-0, page=245 Year: 2004
Assessing nodules detected in lung cancer screening: the value of positron emission tomography Source: Eur Respir J 2015; 45: 314-316 Year: 2015
Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer Source: Eur Respir J 2007; 29: 995-1002 Year: 2007
Positron emission tomography (PET) using ¹⁸F-fluorodeoxyglucose (¹⁸FDG) can detect radiographically ”occult“ lung cancer (ROLC) in the central airways Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001
The use of SPECT in preoperative assessment of patients with lung cancer Source: Eur Respir J 2004; 24: 258-262 Year: 2004
Radiotherapy planning based on positron emission tomography with fluordeoxyglucose in non small cell lung cancer – a pilot study Source: Annual Congress 2008 - Therapy in thoracic oncology Year: 2008
Rebuttal Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005
The relation of fluorine-18 fluorodeoxyglucose positron emission tomography imaging to chemosensitivity for platinum doublet chemotherapy in patients with advanced stage non small cell lung cancer Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer Year: 2009